MarketInOut Stock Screener Log In | Sign Up

Revenio Group Oyj

HEL • Healthcare • Medical Devices • Quote as of 10/27/2026 18:29
Revenio Group Oyj stock price and volume chart

Company Profile

IndustryMedical Devices
SectorHealthcare
ExchangeHEL
Market Capitalization389.19 mln
Float31.62 mln
Earnings Date11/12/2026

EPS

0.41
Marginal

P / E

25.41
Elevated

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-1.72
Likely manipulated

1-Year Forecast

16.37
Exceptional upside

Relative Strength

15 / 100
Significantly lagging

Business Description

Revenio Group Oyj is a Finnish company that develops tools and software for detecting and monitoring eye diseases such as glaucoma, diabetic retinopathy, and macular degeneration. Its product range includes handheld and clinical pressure-measuring devices for both human and animal patients, as well as advanced retinal imaging systems. The company also offers AI-driven screening software and cloud-based platforms that support remote patient care, long-term data storage, and communication between eye care professionals. Founded in 2001 and headquartered in Vantaa, Finland, Revenio sells its products across domestic and international markets.

Key Fundamentals

EPS0.41
P/E25.41
ROE10.93
RPS4.67
ROIC6.62
ROA6.18
Interest Cover58.33
EBITDA, mln23.70
EV / EBITDA28.97
EV / EBIT37.11
Revenue, mln124
EV / Revenue5.55

Quote Details

Last 10.36
Change -0.18 (-1.71%)
Open 10.60
Volume 64,652
Turnover 669,795
Average Volume 70,416

Financial Ratios

Pre-Tax Profit Margin15
Leverage Ratio3.21
Current Ratio0.58
Price / Book2.48
Price / Cash Flow25.85
Price / Free Cash Flow28.11
Debt / Equity1.73
Price / Sales2.82
PEG Ratio3.97

Financial Strength

Altman Z-Score1.19
Piotroski F-Score 4 / 9
Beneish M-Score-1.72
Price to Intrinsic Value1.09
1-Year Target Price16.37
Shiller PE Ratio21.62

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -6.33% 13 / 100   
1 Month -2.08% 65 / 100   
2 Months -12.79% 20 / 100   
6 Months -24.93% 11 / 100   
1 Year -58.56% 6 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog